Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Leukemia Research - Volume 71, August 2018, Pages 55-59

Sotirios G. Papageorgiou, Ioannis Kotsianidis, Christos K. Kontos, Argyris Symeonidis, Athanasios Galanopoulos, Eleftheria Hatzimichael, Elias Poulakidas, Panagiotis Diamantopoulos, Theodoros P. Vassilakopoulos, Panagiotis Zikos, Helen Papadaki,